Create an account to read this article
You need to create an account to read this article.
Create Account Sign in
Nephrology
Diabetes and Endocrinology
Cardiology and CTVS
Medicine
SGLT2 Inhibitor Ertugliflozin Fails To Prevent HF Hospitalization At EF>60 Percent: VERTIS CV Analyses
0 Comments
Post a comment
No comments yet. Be the first to comment!